O
ELGX

OppenheimerFunds’s Endologix Inc ELGX Stock Holding History

OppenheimerFunds’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-63,227
Closed -$6.7M – 986
2014
Q3 		$6.7M Sell
63,227
-272
-0.4% -$37.9K 0.01% 812
2014
Q2 		$9.66M Sell
63,499
-13,310
-17% -$1.77M 0.01% 760
2014
Q1 		$9.89M Buy
+76,809
New +$11.9M 0.01% 756

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OppenheimerFunds's ELGX Position: Q4 2014 in Review

OppenheimerFunds sold out of Endologix Inc (ELGX) in Q4 2014, closing a stake of 63,227 shares — an estimated $6.7M sold.

OppenheimerFunds first reported a position in ELGX in Q1 2014 and held it in 3 quarters. The position peaked at $9.89M in Q1 2014. 122 funds tracked by Wall St. Rank hold ELGX as of Q4 2014.

  • OppenheimerFunds reported no remaining Endologix Inc position as of Q4 2014 after selling out during the quarter.
  • OppenheimerFunds sold 63,227 Endologix Inc shares in Q4 2014, an estimated $6.7M.
  • OppenheimerFunds first reported a position in Endologix Inc in Q1 2014 and held it in 3 quarters.
  • OppenheimerFunds's Endologix Inc position peaked at $9.89M in Q1 2014.
  • 122 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2014.

Based on OppenheimerFunds's 13F filing for Q4 2014, filed 11 Feb 2015.